Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.
|Translated title of the contribution||Frailty in end stage renal disease: Current perspectives|
|Number of pages||9|
|Publication status||Published - 01-09-2022|
All Science Journal Classification (ASJC) codes